RIVAROXABAN-RZ rivaroxaban 15 mg tablet blister pack

البلد: أستراليا

اللغة: الإنجليزية

المصدر: Department of Health (Therapeutic Goods Administration)

العنصر النشط:

rivaroxaban, Quantity: 15 mg

متاح من:

Dr Reddys Laboratories Australia Pty Ltd

الشكل الصيدلاني:

Tablet, film coated

تركيب:

Excipient Ingredients: lactose monohydrate; croscarmellose sodium; iron oxide red; titanium dioxide; magnesium stearate; sodium lauryl sulfate; macrogol 4000; microcrystalline cellulose; hypromellose

طريقة التعاطي:

Oral

الوحدات في الحزمة:

42, 98, 7, 100, 14, 84, 28

نوع الوصفة الطبية :

(S4) Prescription Only Medicine

الخصائص العلاجية:

Rivaroxaban is indicated for:,? Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke.,? Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and for the prevention of recurrent DVT and PE.

ملخص المنتج:

Visual Identification: Red coloured, round biconvex film-coated tablets, engraved with '15' on one side and plain on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

الوضع إذن:

Registered

تاريخ الترخيص:

2023-01-04